The recommended dosage for Semaglutide is as follows: 0.25 mg once weekly for the first 4 weeks 0.5 mg once weekly for at least 4 weeks 1 mg once weekly for at least 4 weeks, but only if additional glycemic control is needed 2mg once weekly if additional control is needed Semaglutide injections should be dosed subcutaneously
Modernized or replaced ultrasound equipment, operating room equipment, x-ray machines, anesthesia machines, defibrillators, and imaging workstations, among many other improvements
But the drugs also carry numerous potential side effects as well as increased pancreatitis risk
Still, the broader trend toward earlier initiation reflects a larger paradigm shift in diabetes care, where patients increasingly benefit from the use of GLP-1s early in their treatment journey
As with any new medication, I suggest you have a discussion with your AME prior to starting the medication